Synthetic Analogues of the Marine Bisindole Deoxytopsentin: Potent Selective Inhibitors of MRSA Pyruvate Kinase
Authors:
- Clinton G. L. VealeCVClinton G. L. Veale
- Roya ZoraghiRZRoya Zoraghi
- James P. MorrisonJMJames P. Morrison
- Manoja PretheebanMPManoja Pretheeban
- Kevin A. LobbKevin A. Lobb
- Neil E. ReinerNRNeil E. Reiner
- Raymond J. AndersenRARaymond J. Andersen
- Michael T. Davies-ColemanMDMichael T. Davies-Coleman
- 5 November 2014
- journal article
- review article
- Published by American Chemical Society (ACS) in Journal of Natural Products
- Vol. 78 (3) , 355-362
Abstract
As part of an ongoing study to elucidate the SAR of bisindole alkaloid inhibitors against the evolutionary conserved MRSA pyruvate kinase (PK), we present here the synthesis and biological activity of six dihalogenated analogues of the naturally occurring sponge metabolite deoxytopsentin, including the naturally occurring dibromodeoxytopsentin. The most active compounds displayed potent low nanomolar inhibitory activity against MRSA PK with concomitant significant selectivity for MRSA PK over human PK orthologues. Computational studies suggest that these potent MRSA PK inhibitors occupy a region of the small interface of the enzyme tetramer where amino acid sequence divergence from common human PK orthologues may contribute to the observed selectivity.Keywords
Funding Information
- Natural Sciences and Engineering Research Council of Canada
- Genome British Columbia
- South African Medical Research Council
- German Academic Exchange Service
- Genome Canada
This publication has 39 references indexed in Scilit:
- How allosteric control of Staphylococcus aureus penicillin binding protein 2a enables methicillin resistance and physiological functionProceedings of the National Academy of Sciences, 2013
- Protein interaction networks as starting points to identify novel antimicrobial drug targetsCurrent Opinion in Microbiology, 2013
- Optimization and structure–activity relationships of a series of potent inhibitors of methicillin-resistant Staphylococcus aureus (MRSA) pyruvate kinase as novel antimicrobial agentsBioorganic & Medicinal Chemistry, 2012
- Identification of Pyruvate Kinase in Methicillin-Resistant Staphylococcus aureus as a Novel Antimicrobial Drug TargetAntimicrobial Agents and Chemotherapy, 2011
- Alternatives to Vancomycin for the Treatment of Methicillin-Resistant Staphylococcus aureus InfectionsClinical Infectious Diseases, 2007
- Decreased susceptibility to glycopeptides in methicillin-resistant Staphylococcus aureus: a 20 year study in a large French teaching hospital, 1983–2002Journal of Antimicrobial Chemotherapy, 2006
- Adaptation of Methicillin-Resistant Staphylococcus aureus in the Face of Vancomycin TherapyClinical Infectious Diseases, 2006
- The emergence and evolution of methicillin-resistant Staphylococcus aureusTrends in Microbiology, 2001
- Penicillin-binding proteins and bacterial resistance to beta-lactamsAntimicrobial Agents and Chemotherapy, 1993
- Expression and inducibility in Staphylococcus aureus of the mecA gene, which encodes a methicillin-resistant S. aureus-specific penicillin-binding proteinJournal of Bacteriology, 1989